AGIO Agios Pharmaceuticals, Inc. - Common Stock
Sobre Agios Pharmaceuticals, Inc. - Common Stock Visão geral da empresa da Wikipedia
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Ler mais
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
History
In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios.
In May 2016, the company announced it would launch partnership with Celgene, developing metabolic immuno-oncology therapies and licensing AG-221 as well as AG-881 to Celgene, potentially garnering Agios $120 million in drug licensing payments.
In April 2017, the company raised $250 million in a new stock offering in anticipation of approval for its first cancer drug, enasidenib, by the US Food and Drug Administration.
In December 2017, the company filed a New Drug Application with the US FDA for ivosidenib for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with an IDH1 mutation.
In November 2019, Agios announced an underwritten public offering of 8,250,000 shares of common stock at a price of $31.00 per share which would result in approximately $256 million aggregate gross proceeds.
In April 2022, the FDA approved mitapivat as first disease-modifying therapy for hemolytic anemia in adults with pyruvate kinase deficiency.
Corporate governance
As of August 2022, Agios' CEO is Brian Goff.
Agios was established as a private company and converted to a public company with its initial public offering in July 2013 and subsequent listing on NASDAQ.
== References ==
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
AGIO Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
AGIO Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
AGIO Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 5 31,2%
- Compra 7 43,8%
- Manter 4 25,0%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
8 analistas · 2026-08-16Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $-1.69 | $-1.70 | 0.01% |
| 31 de Março de 2026 | $-1.69 | $-1.84 | 0.15% |
| 31 de Dezembro de 2025 | $-1.86 | $-1.99 | 0.13% |
| 30 de Setembro de 2025 | $-1.78 | $-1.94 | 0.16% |
| 30 de Junho de 2025 | $-1.93 | $-1.84 | -0.09% |
| 31 de Março de 2025 | $-1.55 | $-1.82 | 0.27% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| GENB | — | — | — | — | — | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Cost of Revenue | $6M | $4M | $3M | $2M | $0 | $0 | $1M | $1M | $0 | $0 | · | · | |
| R&D Expense | $340M | $301M | $296M | $280M | $257M | $221M | $214M | $341M | $293M | $220M | $142M | $100M | |
| SG&A Expense | $180M | $157M | $120M | $122M | $121M | $115M | $102M | $114M | $71M | $51M | $36M | $19M | |
| Operating Expenses | $526M | $462M | $418M | $403M | $378M | $336M | $316M | $457M | $364M | $271M | $178M | $119M | |
| Operating Income | $-472M | $-426M | $-391M | $-389M | $-378M | $-336M | $-316M | $-362M | $-321M | $-201M | $-119M | $-54M | |
| Interest Income | · | · | · | $13M | $836.0K | $7M | $15M | $16M | $6M | $3M | $968.0K | $203.0K | |
| Other Non-op | $2M | $6M | $6M | $7M | $14M | $0 | $0 | · | · | · | · | · | |
| Pretax Income | $-414M | $718M | $-352M | $-232M | $-357M | $-329M | $-301M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Income Tax | $-1M | $44M | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $-426.0K | |
| Net Income | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| EPS (Basic) | $-7.12 | $11.86 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| EPS (Diluted) | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| Shares (Basic) | 57,972,004 | 56,807,415 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| Shares (Diluted) | 57,972,004 | 57,889,255 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| EBITDA | $-472M | $-426M | $-391M | $-389M | $-378M | $-316M | $-418M | $-362M | $-321M | $-201M | $-119M | $-54M |
Balanço Patrimonial 22
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $76M | $88M | $139M | $203M | $127M | $81M | $71M | $103M | $161M | $72M | $14M | |
| Short-term Investments | · | · | · | · | · | · | · | $515M | $321M | $381M | · | · | |
| Inventory | $33M | $28M | $19M | $8M | $0 | $15M | $7M | $869.0K | $0 | · | · | · | |
| Prepaid Expense | $44M | $40M | $35M | $39M | $40M | $16M | $24M | $17M | $18M | $10M | $9M | $5M | |
| Current Assets | $942M | $966M | $834M | $833M | $1.06B | $637M | $612M | $614M | $445M | $560M | $337M | $360M | |
| PP&E (Net) | $11M | $12M | $15M | $23M | $29M | $31M | $31M | $24M | $24M | $25M | $23M | $6M | |
| PP&E (Gross) | $71M | $68M | $68M | $73M | $74M | $72M | $64M | $50M | $44M | $39M | $31M | $12M | |
| Accum. Depreciation | $60M | $56M | $52M | $50M | $45M | $41M | $32M | $26M | $19M | $13M | $8M | $6M | |
| Other Non-current Assets | $4M | $5M | $4M | $4M | $3M | $0 | $0 | $238.0K | $891.0K | $2M | $611.0K | $590.0K | |
| Total Assets | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Accounts Payable | $18M | $17M | $10M | $19M | $17M | $18M | $22M | $18M | $23M | $17M | $15M | $11M | |
| Accrued Liabilities | $45M | $47M | $43M | $30M | $32M | $31M | $53M | $42M | $34M | $32M | $16M | $14M | |
| Current Liabilities | $82M | $81M | $68M | $63M | $60M | $94M | $93M | $94M | $95M | $88M | $53M | $61M | |
| Capital Leases | $22M | $40M | $57M | $72M | $86M | $97M | $106M | · | · | · | · | · | |
| Other Non-current Liabilities | $90.0K | $880.0K | $1M | $3M | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $104M | $122M | $126M | $138M | $146M | $453M | $250M | $171M | $239M | $261M | · | · | |
| Common Stock | · | · | · | · | $71.0K | $69.0K | $68.0K | $58.0K | $49.0K | $42.0K | $38.0K | $37.0K | |
| Retained Earnings | $-562M | $-149M | $-823M | $-471M | $-239M | $-1.84B | $-1.52B | $-1.10B | $-798M | $-483M | $-285M | $-167M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $0 | · | · | · | · | · | · | |
| Stockholders' Equity | $1.19B | $1.54B | $811M | $1.10B | $1.29B | $400M | $641M | $688M | $376M | $359M | $345M | $424M | |
| Liabilities + Equity | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Shares Outstanding | 58,448,592 | 73,372,696,000 | 72,161,489 | 71,256,118 | 70,550,631 | 69,293,920 | 68,401,105 | 58,218,653 | 48,826,153 | 42,220,444 | 37,696,502 | 37,100,513 |
Fluxo de Caixa 13
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $8M | $7M | $6M | · | · | · | |
| Stock-based Comp | $53M | $43M | $45M | $49M | $54M | $62M | $58M | $73M | $48M | $42M | $32M | $12M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | · | · | · | $-40M | · | · | · | · | · | |
| Operating Cash Flow | $-373M | $-390M | $-296M | $-309M | $-407M | $-291M | $-371M | $-304M | $-285M | $39M | $-77M | $-59M | |
| CapEx | $4M | $2M | $999.0K | $5M | $6M | $14M | $12M | $7M | $5M | $10M | $20M | $2M | |
| Investing Cash Flow | $377M | $363M | $240M | $243M | $1.25B | $76M | $91M | $-274M | $-58M | $-119M | $128M | · | |
| Stock Issued | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | $0 | $334M | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | · | $334M | |
| Financing Cash Flow | $9M | $14M | $5M | $2M | $-766M | $262M | $290M | $546M | $285M | $170M | $6M | · | |
| Net Change in Cash | $13M | $-12M | $-51M | $-64M | $76M | $47M | $10M | $-32M | $-58M | $89M | $58M | $-58M | |
| Taxes Paid | $628.0K | $43M | $2M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-377M | $-392M | $-297M | $-314M | $-413M | $-306M | $-383M | $-311M | $-290M | $29M | $-97M | $-62M |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -361.6% | · | -745.8% | · | · | -82.8% | |
| Net Margin | -764.0% | 1845.9% | -1312.6% | -1627.8% | · | -161.1% | -349.0% | · | -731.6% | · | · | -81.9% | |
| Pretax Margin | -765.9% | 1967.2% | -1312.6% | -1627.8% | · | -161.2% | -349.0% | · | -731.6% | · | · | -82.5% | |
| EBITDA Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -354.7% | · | -745.8% | · | · | -82.8% | |
| ROA | -27.9% | 51.8% | -32.4% | -17.3% | 140.1% | -37.5% | -47.0% | -47.0% | -51.0% | -38.2% | -25.8% | -15.4% | |
| ROE | -32.2% | 42.5% | -41.5% | -21.6% | 119.4% | -74.4% | -75.6% | -47.8% | -85.7% | -56.4% | -30.6% | -19.2% | |
| ROIC | -39.5% | -25.9% | · | · | · | · | -66.6% | -52.7% | -85.4% | · | · | -12.7% |
Liquidez e Solvência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 | 6.7 | 6.6 | 6.6 | 4.7 | 6.3 | 6.4 | 5.9 | |
| Quick Ratio | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 | 1.4 | 0.9 | 6.3 | 4.5 | 1.8 | 1.4 | 0.2 |
Eficiência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.1 | · | 0.1 | · | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.2 | 0.2 | 0.4 | · | 0.3 | 0.3 | 3.2 | · | · | · | · |
Taxas de Crescimento 4
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 48.0% | 36.1% | 88.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 56.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -24.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -25.1% | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Net Income TTM | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Market Cap | $1.59B | $1.88B | $1.25B | $1.55B | $1.79B | $3.00B | $3.27B | $2.68B | $2.79B | $1.76B | $2.45B | $4.16B | |
| P/E | -3.8 | 2.8 | -3.5 | -6.6 | 1.2 | -9.1 | -7.0 | · | · | · | · | -70.5 | |
| P/S | 29.4 | 51.5 | 46.4 | 108.5 | · | · | 27.7 | 28.4 | 64.9 | 25.2 | 41.4 | 63.6 | |
| P/B | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | 5.1 | 3.9 | 7.4 | 4.9 | 7.1 | 9.8 | |
| P / Tangible Book | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | · | · | · | · | · | · | |
| P / Cash Flow | -4.3 | -4.8 | -4.2 | -5.0 | -4.4 | -10.3 | -8.8 | -8.8 | -9.8 | 45.7 | -31.8 | -70.0 | |
| P / FCF | -4.2 | -4.8 | -4.2 | -4.9 | -4.3 | -9.8 | -8.5 | -8.6 | -9.6 | 61.5 | -25.2 | -67.5 | |
| Earnings Yield | -26.2% | 35.4% | -28.4% | -15.1% | 80.8% | -10.9% | -14.4% | · | · | · | · | -1.4% |
Demonstração de Resultados 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $21M | $20M | $13M | $12M | $9M | $11M | $9M | $9M | $8M | $7M | $7M | $7M | $6M | $4M | $4M | |
| Cost of Revenue | $3M | $1M | $2M | $2M | $2M | $1M | $1M | $783.0K | $1M | $627.0K | $586.0K | $633.0K | $1M | $554.0K | $413.0K | $517.0K | |
| R&D Expense | $101M | $81M | $88M | $87M | $92M | $73M | $83M | $72M | $77M | $69M | $77M | $82M | $69M | $67M | $70M | $65M | |
| SG&A Expense | $52M | $48M | $52M | $41M | $46M | $42M | $52M | $39M | $36M | $31M | $35M | $26M | $30M | $28M | $33M | $29M | |
| Operating Expenses | $155M | $131M | $142M | $130M | $140M | $115M | $136M | $112M | $114M | $100M | $113M | $108M | $100M | $96M | $103M | $95M | |
| Operating Income | $-111M | $-110M | $-122M | $-117M | $-127M | $-107M | $-125M | $-103M | $-106M | $-92M | $-106M | $-101M | $-94M | $-91M | $-99M | $-91M | |
| Other Non-op | $119.0K | $119.0K | $113.0K | $67.0K | $523.0K | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | |
| Pretax Income | · | · | $-109M | $-103M | · | · | $-105M | $1.00B | · | · | $-96M | $-91M | · | · | · | · | |
| Income Tax | · | · | $-1M | $0 | · | · | $-9M | $53M | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Income | $-101M | $-99M | $-108M | $-103M | $-112M | $-89M | $-97M | $948M | $-96M | $-82M | $-96M | $-91M | $-84M | $-81M | $37M | $-82M | |
| EPS (Basic) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.65 | $16.65 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| EPS (Diluted) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.44 | $16.22 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| Shares (Basic) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,318,009 | 56,939,403 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| Shares (Diluted) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,729,562 | 58,432,796 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| EBITDA | $-111M | $-110M | · | $-117M | $-127M | $-107M | · | $-103M | $-106M | $-92M | · | $-101M | $-94M | $-91M | · | $-91M |
Balanço Patrimonial 20
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100M | $114M | $89M | $93M | $81M | $79M | $76M | $254M | $85M | $119M | · | $64M | $85M | $104M | · | $122M | |
| Inventory | $36M | $35M | $33M | $32M | $31M | $30M | $28M | $26M | $24M | $23M | · | $17M | $16M | $11M | · | $5M | |
| Prepaid Expense | $46M | $47M | $44M | $43M | $45M | $42M | $40M | $40M | $35M | $39M | · | $38M | $37M | $39M | · | $46M | |
| Current Assets | $718M | $835M | $942M | $1.03B | $1.02B | $969M | $966M | $1.07B | $632M | $664M | · | $704M | $757M | $792M | · | $785M | |
| PP&E (Net) | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $13M | $14M | · | $17M | $20M | $21M | · | $25M | |
| PP&E (Gross) | · | · | $71M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $60M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $10M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Total Assets | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Accounts Payable | $16M | $14M | $18M | $20M | $18M | $14M | $17M | $17M | $10M | $11M | · | $13M | $12M | $9M | · | $10M | |
| Accrued Liabilities | $35M | $26M | $45M | $37M | $35M | $21M | $47M | $33M | $37M | $25M | · | $30M | $29M | $22M | · | $30M | |
| Current Liabilities | $70M | $59M | $82M | $75M | $70M | $52M | $81M | $119M | $63M | $52M | · | $58M | $55M | $45M | · | $54M | |
| Capital Leases | $12M | $17M | $22M | $27M | $31M | $36M | $40M | $45M | $49M | $53M | · | $61M | $65M | $68M | · | $75M | |
| Other Non-current Liabilities | $240.0K | $90.0K | $90.0K | $90.0K | $101.0K | $880.0K | $880.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $82M | $76M | $104M | $101M | $102M | $89M | $122M | $165M | $113M | $106M | · | $120M | $121M | $115M | · | $130M | |
| Retained Earnings | $-762M | $-661M | $-562M | $-454M | $-350M | $-238M | $-149M | $-52M | $-1.00B | $-904M | · | $-727M | $-635M | $-552M | · | $-507M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | · | $802M | $802M | $802M | · | $802M | |
| Stockholders' Equity | $1.03B | $1.11B | $1.19B | $1.28B | $1.37B | $1.47B | $1.54B | $1.63B | $661M | $744M | $811M | $887M | $964M | $1.04B | $1.10B | $1.05B | |
| Liabilities + Equity | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Shares Outstanding | 59,604,830 | 59,341,338 | 58,448,592 | 58,279,876 | 58,038,545 | 57,886,781 | 57,156,285 | 57,021,543 | 56,875,079 | 56,751,511 | 72,161,489 | 55,883,973 | 55,734,775 | 55,541,367 | 71,256,118 | 54,894,031 |
Fluxo de Caixa 9
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $16M | $16M | $14M | $12M | $15M | $11M | $11M | $11M | $12M | $9M | $14M | $9M | $12M | $10M | $11M | $11M | |
| Operating Cash Flow | $-57M | $-119M | $-96M | $-88M | $-77M | $-111M | $-133M | $-84M | $-73M | $-100M | $-72M | $-62M | $-67M | $-95M | $-66M | $-71M | |
| CapEx | $1M | $769.0K | $1M | $2M | $875.0K | $766.0K | $967.0K | $419.0K | $158.0K | $141.0K | $234.0K | $369.0K | $-3.0K | $399.0K | $113.0K | $38.0K | |
| Investing Cash Flow | $40M | $141M | $90M | $96M | $79M | $113M | $-49M | $251M | $37M | $125M | $96M | $39M | $47M | $58M | $83M | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $3M | $2M | $3M | $4M | $65.0K | $2M | $5M | $3M | $1M | $6M | $847.0K | $2M | $237.0K | $2M | $22.0K | $1M | |
| Net Change in Cash | $-14M | $24M | $-4M | $12M | $2M | $3M | $-177M | $169M | $-34M | $31M | $24M | $-20M | $-19M | $-35M | $17M | $34M | |
| Taxes Paid | $70.0K | $4.0K | $-940.0K | $65.0K | $1M | $188.0K | $44M | $-34.0K | $-78.0K | $-525.0K | $-17.0K | $785.0K | $801.0K | $0 | · | $98.0K | |
| Free Cash Flow | · | $-120M | · | · | · | $-112M | · | · | · | $-100M | · | · | · | $-96M | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| Net Margin | -225.1% | -477.7% | · | -803.0% | -899.4% | -1023.2% | · | 10574.7% | -1115.7% | -995.8% | · | -1234.3% | -1248.6% | -1444.4% | · | -2325.0% | |
| Pretax Margin | · | · | · | -803.0% | · | · | · | 11167.3% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| ROA | -7.8% | -7.2% | · | -6.5% | -10.0% | -7.4% | · | 67.7% | -10.3% | -8.2% | · | -8.3% | -7.2% | -6.5% | · | -6.0% | |
| ROE | -8.4% | -7.7% | · | -7.1% | -11.0% | -8.1% | · | 75.4% | -11.8% | -9.2% | · | -9.4% | -8.0% | -7.2% | · | -6.7% | |
| ROIC | · | · | · | -9.1% | · | · | · | -6.0% | · | · | · | · | · | · | · | · |
Liquidez e Solvência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 14.2 | · | 13.8 | 14.5 | 18.5 | · | 9.0 | 10.1 | 12.8 | · | 12.1 | 13.7 | 17.5 | · | 14.6 | |
| Quick Ratio | 1.4 | 1.9 | · | 1.2 | 1.1 | 1.5 | · | 2.1 | 1.3 | 2.3 | · | 1.1 | 1.5 | 2.3 | · | 2.3 |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $91M | $55M | · | $43M | $39M | $34M | · | $33M | $31M | $28M | · | $23M | $21M | $16M | · | $10M | |
| Net Income TTM | $-415M | $-404M | · | $643M | $650M | $681M | · | $679M | $-353M | $-338M | · | $-338M | $-338M | $-349M | · | $-357M | |
| Market Cap | $2.21B | $2.01B | · | $2.34B | $1.93B | $1.70B | · | $2.53B | $2.45B | $1.66B | · | $1.38B | $1.58B | $1.28B | · | $1.55B | |
| P/E | -5.2 | -4.9 | · | 3.7 | 3.0 | 2.5 | · | 3.9 | -6.9 | -4.8 | · | -4.1 | -4.6 | -3.6 | · | -4.3 | |
| P/S | 24.4 | 36.6 | · | 54.4 | 49.8 | 49.2 | · | 76.4 | 79.3 | 59.5 | · | 59.5 | 73.7 | 82.1 | · | 156.3 | |
| P/B | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Tangible Book | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Cash Flow | · | -16.9 | · | · | · | -15.2 | · | · | · | -16.6 | · | · | · | -13.4 | · | · | |
| P / FCF | · | -16.8 | · | · | · | -15.1 | · | · | · | -16.6 | · | · | · | -13.3 | · | · | |
| Earnings Yield | -19.1% | -20.5% | · | 27.3% | 33.2% | 39.4% | · | 25.8% | -14.6% | -20.8% | · | -24.7% | -21.7% | -27.8% | · | -23.5% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $54M | $36M | $27M | $14M | $0 |
| Margem Operacional % | -873.9% | -1166.5% | -1459.5% | -2732.1% | — |
| Lucro líquido | $-413M | $674M | $-352M | $-232M | $1.60B |
| EPS Diluído | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 |
| Índice de Liquidez Seca | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-377M | $-392M | $-297M | $-314M | $-413M |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 264 declarantes · $2.0B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 46 (+12 vs trimestre anterior) | 30 (-3 vs trimestre anterior) | 95 (+17 vs trimestre anterior) | 62 (-27 vs trimestre anterior) | +12.7M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $219.594.714 | 5.917.400 | 11,17% | Ações |
| STATE STREET CORP | $131.144.972 | 3.533.633 | 6,67% | Ações |
| Lynx1 Capital Management LP | $126.505.652 | 3.408.937 | 6,43% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107.552.091 | 2.898.197 | 5,47% | Ações |
| ARMISTICE CAPITAL, LLC | $104.279.100 | 2.810.000 | 5,30% | Opção de compra |
| VANGUARD CAPITAL MANAGEMENT LLC | $99.523.268 | 2.681.845 | 5,06% | Ações |
| ARMISTICE CAPITAL, LLC | $89.064.000 | 2.400.000 | 4,53% | Ações |
| Erste Asset Management GmbH | $81.972.396 | 2.154.900 | 4,17% | Ações |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $78.332.000 | 2.110.809 | 3,98% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $51.046.957 | 1.375.558 | 2,60% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $50.151.466 | 1.351.093 | 2,55% | Ações |
| ADAR1 Capital Management, LLC | $47.799.647 | 1.288.053 | 2,43% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $44.225.805 | 1.191.749 | 2,25% | Ações |
| GOLDMAN SACHS GROUP INC | $36.642.971 | 987.415 | 1,86% | Ações |
| D. E. Shaw & Co., Inc. | $34.087.168 | 918.544 | 1,73% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $30.078.768 | 810.530 | 1,53% | Ações |
| Foresite Capital Management VI LLC | $29.131.350 | 785.000 | 1,48% | Ações |
| CITADEL ADVISORS LLC | $26.154.683 | 704.788 | 1,33% | Ações |
| Parkman Healthcare Partners LLC | $24.828.297 | 669.046 | 1,26% | Ações |
| SCS Capital Management LLC | $22.742.864 | 612.850 | 1,16% | Ações |
| Qube Research & Technologies Ltd | $22.178.346 | 597.638 | 1,13% | Ações |
| Defilade Capital Management, L.P. | $20.293.529 | 546.848 | 1,03% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19.969.930 | 538.128 | 1,02% | Ações |
| TWO SIGMA INVESTMENTS, LP | $19.905.062 | 536.380 | 1,01% | Ações |
| Rock Springs Capital Management LP | $19.763.413 | 532.563 | 1,01% | Ações |
| Schonfeld Strategic Advisors LLC | $19.300.279 | 520.083 | 0,98% | Ações |
| Point72 Asset Management, L.P. | $18.790.426 | 506.344 | 0,96% | Ações |
| JANE STREET GROUP, LLC | $18.280.312 | 492.598 | 0,93% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $14.690.661 | 395.868 | 0,75% | Ações |
| PANAGORA ASSET MANAGEMENT INC | $13.876.579 | 373.931 | 0,71% | Ações |
| KENNEDY CAPITAL MANAGEMENT LLC | $13.850.565 | 373.230 | 0,70% | Ações |
| Connor, Clark & Lunn Investment Management Ltd. | $13.342.901 | 359.550 | 0,68% | Ações |
| Squarepoint Ops LLC | $11.917.431 | 321.138 | 0,61% | Ações |
| JPMORGAN CHASE & CO | $11.853.074 | 309.008 | 0,60% | Ações |
| Ensign Peak Advisors, Inc | $11.045.049 | 297.630 | 0,56% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $9.996.803 | 269.383 | 0,51% | Ações |
| ALGERT GLOBAL LLC | $9.203.540 | 248.007 | 0,47% | Ações |
| JANE STREET GROUP, LLC | $7.974.939 | 214.900 | 0,41% | Opção de venda |
| Palo Alto Investors LP | $7.926.733 | 213.601 | 0,40% | Ações |
| Tetragon Partners GP Ltd | $7.629.037 | 205.579 | 0,39% | Ações |
| AXA Investment Managers S.A. | $7.131.875 | 177.675 | 0,36% | Ações |
| Cutter Capital Management, LP | $6.895.755 | 235.350 | 0,35% | Ações |
| BlackRock, Inc. | $6.545.388 | 176.378 | 0,33% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.334.677 | 170.700 | 0,32% | Opção de compra |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $6.306.139 | 169.931 | 0,32% | Ações |
| FIRST TRUST ADVISORS LP | $6.144.933 | 165.587 | 0,31% | Ações |
| Ishara Investments LP | $6.086.040 | 164.000 | 0,31% | Ações |
| GROUP ONE TRADING LLC | $5.640.497 | 151.994 | 0,29% | Ações |
| BOOTHBAY FUND MANAGEMENT, LLC | $5.562.269 | 149.886 | 0,28% | Ações |
| BANK OF AMERICA CORP /DE/ | $5.505.083 | 148.345 | 0,28% | Ações |
| MARSHALL WACE, LLP | $5.150.868 | 138.800 | 0,26% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.080.359 | 136.900 | 0,26% | Opção de venda |
| AMERICAN CENTURY COMPANIES INC | $4.991.740 | 134.512 | 0,25% | Ações |
| Man Group plc | $4.617.931 | 124.439 | 0,23% | Ações |
| ArrowMark Colorado Holdings LLC | $4.368.367 | 117.714 | 0,22% | Ações |
| Pictet Asset Management Holding SA | $4.247.606 | 111.861 | 0,22% | Ações |
| Swiss National Bank | $4.143.703 | 111.660 | 0,21% | Ações |
| CAPITAL FUND MANAGEMENT S.A. | $3.862.408 | 104.080 | 0,20% | Ações |
| Assenagon Asset Management S.A. | $3.857.770 | 103.955 | 0,20% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.700.831 | 99.726 | 0,19% | Ações |
| Knott David M Jr | $3.527.602 | 95.058 | 0,18% | Ações |
| Trexquant Investment LP | $3.471.232 | 93.539 | 0,18% | Ações |
| CITADEL ADVISORS LLC | $3.402.987 | 91.700 | 0,17% | Opção de compra |
| Jain Global LLC | $3.401.020 | 91.647 | 0,17% | Ações |
| Caligan Partners LP | $3.339.900 | 90.000 | 0,17% | Opção de compra |
| CITADEL ADVISORS LLC | $3.295.368 | 88.800 | 0,17% | Opção de venda |
| CITIGROUP INC | $3.182.331 | 85.754 | 0,16% | Ações |
| RHUMBLINE ADVISERS | $2.948.045 | 79.441 | 0,15% | Ações |
| Bank of New York Mellon Corp | $2.916.846 | 78.600 | 0,15% | Ações |
| Campbell & CO Investment Adviser LLC | $2.712.555 | 73.095 | 0,14% | Ações |
| Exome Asset Management LLC | $2.616.255 | 70.500 | 0,13% | Ações |
| Edgestream Partners, L.P. | $2.604.936 | 70.195 | 0,13% | Ações |
| TUDOR INVESTMENT CORP ET AL | $2.441.059 | 65.779 | 0,12% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.319.520 | 68.564 | 0,12% | Ações |
| TWO SIGMA ADVISERS, LP | $2.319.144 | 85.200 | 0,12% | Ações |
| ALPS ADVISORS INC | $2.228.789 | 60.059 | 0,11% | Ações |
| Seven Fleet Capital Management LP | $2.111.559 | 56.900 | 0,11% | Ações |
| ALLIANCEBERNSTEIN L.P. | $2.092.859 | 61.864 | 0,11% | Ações |
| Rafferty Asset Management, LLC | $2.062.574 | 55.580 | 0,10% | Ações |
| Engineers Gate Manager LP | $2.000.674 | 53.912 | 0,10% | Ações |
| WELLS FARGO & COMPANY/MN | $1.935.843 | 52.165 | 0,10% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.931.576 | 52.050 | 0,10% | Ações |
| XTX Topco Ltd | $1.869.082 | 50.366 | 0,10% | Ações |
| Caption Management, LLC | $1.855.500 | 50.000 | 0,09% | Opção de compra |
| Tetragon Partners GP Ltd | $1.855.500 | 50.000 | 0,09% | Opção de compra |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1.846.742 | 49.764 | 0,09% | Ações |
| BARCLAYS PLC | $1.725.651 | 46.501 | 0,09% | Ações |
| Quantinno Capital Management LP | $1.614.805 | 43.514 | 0,08% | Ações |
| MARTINGALE ASSET MANAGEMENT L P | $1.596.064 | 43.009 | 0,08% | Ações |
| IEQ CAPITAL, LLC | $1.499.392 | 40.404 | 0,08% | Ações |
| Kodai Capital Management LP | $1.485.276 | 50.692 | 0,08% | Ações |
| Virtus Investment Advisers, LLC | $1.464.843 | 39.473 | 0,07% | Ações |
| Caption Management, LLC | $1.456.530 | 39.249 | 0,07% | Ações |
| JANE STREET GROUP, LLC | $1.451.001 | 39.100 | 0,07% | Opção de compra |
| FMR LLC | $1.446.325 | 38.974 | 0,07% | Ações |
| Aquatic Capital Management LLC | $1.433.448 | 38.627 | 0,07% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.400.049 | 37.727 | 0,07% | Ações |
| VANGUARD GROUP INC | $1.308.928 | 48.087 | 0,07% | Ações |
| EDGEWOOD MANAGEMENT LLC | $1.298.850 | 35.000 | 0,07% | Ações |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.298.776 | 34.998 | 0,07% | Ações |
Executivos da empresa 33 insiders · 12 diretores · 19 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Brian Goff | Chief Executive Officer | 18 de Junho de 2026 A | — | 0 | 0 | $0 |
| Cecilia Jones | Chief Financial Officer | 18 de Junho de 2026 A | — | 0 | 0 | $0 |
| Andrew Hirsch | Chief Financial Officer | 22 de Abril de 2019 A | 12.374 | 0 | 0 | $0 |
| John Duncan Higgons | Chief Operating Officer | 4 de Janeiro de 2016 M | 120.834 | 0 | 0 | $0 |
| Krishnan Viswanadhan | Chief Strategy and Operations | 18 de Junho de 2026 A | — | 0 | 0 | $0 |
| Tsveta Milanova | Chief Commercial Officer | 18 de Junho de 2026 A | — | 0 | 0 | $0 |
| James William Burns | Chief Legal Officer | 18 de Junho de 2026 A | — | 0 | 0 | $0 |
| Scott Biller | Chief Scientific Officer | 5 de Abril de 2019 M | 26.511 | 0 | 0 | $0 |
| Christopher Bowden | Chief Medical Officer | 1 de Abril de 2019 M | 7.238 | 0 | 0 | $0 |
| Steven L. Hoerter | Chief Commercial Officer | 4 de Março de 2019 M | 10.941 | 0 | 0 | $0 |
| Carman Alenson | Principal Accounting Officer | 22 de Fevereiro de 2019 A | 2.796 | 0 | 0 | $0 |
| Glenn Goddard | Senior Vice President, Finance | 16 de Fevereiro de 2016 A | 0 | 0 | 0 | $0 |
| Adams Catherine Owen | Conselheiro | 18 de Junho de 2026 A | 10.865 | 0 | 0 | $0 |
| Rahul D. Ballal | Conselheiro | 18 de Junho de 2026 A | 15.230 | 0 | 0 | $0 |
| David Scadden | Conselheiro | 18 de Junho de 2026 A | 20.419 | 0 | 0 | $0 |
| Maykin Ho | Conselheiro | 18 de Junho de 2026 A | 19.848 | 0 | 0 | $0 |
| Cynthia Smith | Conselheiro | 18 de Junho de 2026 A | 15.230 | 0 | 0 | $0 |
| Jacqualyn A Fouse | Conselheiro | 18 de Junho de 2026 A | 154.156 | 0 | 0 | $0 |
| Kaye I Foster-Cheek | Conselheiro | 18 de Junho de 2026 A | 10.284 | 0 | 0 | $0 |
| Jeffrey D Capello | Conselheiro | 18 de Junho de 2026 A | 10.865 | 0 | 0 | $0 |
| Paul J Clancy | Conselheiro | 31 de Maio de 2019 M | 1.400 | 0 | 0 | $0 |
| Ian T Clark | Conselheiro | 31 de Maio de 2019 M | 1.400 | 0 | 0 | $0 |
| John Maraganore | Conselheiro | 31 de Maio de 2019 M | 37.609 | 0 | 0 | $0 |
| David P Schenkein | Conselheiro | 22 de Fevereiro de 2019 A | 89.503 | 0 | 0 | $0 |
| Lewis Clayton Cantley Jr. | Conselheiro | 7 de Dezembro de 2017 S | 79.515 | 0 | 0 | $0 |
| Robert Nelsen | Conselheiro | 6 de Março de 2017 S | 0 | 0 | 0 | $0 |
| Douglas G. Cole | Conselheiro | 10 de Agosto de 2016 J | 2.778 | 0 | 0 | $0 |
| Marc Tessier-Lavigne | Conselheiro | 21 de Junho de 2016 A | 101.009 | 0 | 0 | $0 |
| Perry A Karsen | Conselheiro | 23 de Junho de 2015 A | — | 0 | 0 | $0 |
| Kevin P Starr | Conselheiro | 19 de Fevereiro de 2015 J | 184.386 | 0 | 0 | $0 |
| Celgene European Investment Co LLC | Detentor de 10% | 16 de Dezembro de 2014 P | 1.231.778 | 0 | 0 | $0 |
| Sarah Gheuens | — | 4 de Agosto de 2026 S | 54.645 | 0 | 2 | $-1.064.903 |
| Jay T. Backstrom | — | 8 de Julho de 2026 M | 1.447 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 3 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY, CELGENE CORPORATION, CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC | 5 de Abril de 2021 | — | Declaração inicial | — | SEC |
| CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 declarações | 14 de Novembro de 2019 | — | Declaração inicial | Estrutura de capital | SEC |
| CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 declarações | 17 de Dezembro de 2014 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 57 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,64% | 34.703 NS | 30 de Abril de 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 1,10% | 60.392 NS | 31 de Maio de 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 0,77% | 43.269 NS | 30 de Abril de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,60% | 110.585 NS | 30 de Abril de 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 3.805 SH | 8 de Agosto de 2026 | Diário |
| AGNG · Global X Funds | 0,28% | 7.695 NS | 31 de Maio de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,27% | 101.599 NS | 30 de Abril de 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,19% | 17.290 SH | 8 de Agosto de 2026 | Diário |
| IBB · iShares Trust | 0,14% | 408.719 SH | 8 de Agosto de 2026 | Diário |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 3.239 SH | 8 de Agosto de 2026 | Diário |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,13% | 48.730 SH | 8 de Agosto de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,13% | 113.617 SH | 8 de Agosto de 2026 | Diário |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,12% | 109.727 NS | 31 de Maio de 2026 | N-PORT |
| IWN · iShares Trust | 0,11% | 515.162 SH | 8 de Agosto de 2026 | Diário |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,09% | 40.934 NS | 30 de Abril de 2026 | N-PORT |
| BIB · ProShares Trust | 0,09% | 2.166 NS | 31 de Maio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,08% | 22.172 NS | 30 de Abril de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 340.226 SH | 8 de Agosto de 2026 | Diário |
| VBK · VANGUARD INDEX FUNDS | 0,06% | 788.655 SH | 8 de Agosto de 2026 | Diário |
| IWM · iShares Trust | 0,06% | 1.508.427 SH | 8 de Agosto de 2026 | Diário |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 9.472 NS | 30 de Abril de 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 48.207 SH | 8 de Agosto de 2026 | Diário |
| RSSL · Global X Funds | 0,05% | 24.449 NS | 30 de Abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,04% | 2.658 NS | 31 de Maio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 193.306 NS | 30 de Abril de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,04% | 280.734 NS | 31 de Maio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,03% | 10.195 SH | 8 de Agosto de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,03% | 1.364.364 SH | 8 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,03% | 167.169 SH | 8 de Agosto de 2026 | Diário |
| ISCB · iShares Trust | 0,03% | 2.463 SH | 8 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 25.231 NS | 30 de Abril de 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2.079 NS | 31 de Maio de 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 5.020 SH | 8 de Agosto de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 683.802 SH | 8 de Agosto de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,02% | 2.762 NS | 30 de Abril de 2026 | N-PORT |
| URTY · ProShares Trust | 0,02% | 2.105 NS | 31 de Maio de 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 5.903 NS | 31 de Maio de 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 3.329 SH | 8 de Agosto de 2026 | Diário |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3.639 SH | 8 de Agosto de 2026 | Diário |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2.328 NS | 31 de Maio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 136.570 NS | 30 de Abril de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 8.867 NS | 30 de Abril de 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 53 NS | 31 de Maio de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 25.095 NS | 31 de Maio de 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 30.958 SH | 8 de Agosto de 2026 | Diário |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,01% | 1.068 NS | 31 de Maio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 4.329 NS | 30 de Abril de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 17.627 NS | 30 de Abril de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 19.324 NS | 30 de Abril de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 16.536 SH | 8 de Agosto de 2026 | Diário |